Where Innovation Meets Impact: MRA 2023 Annual Report

23 January 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Policy, Prevention, Science, Treatment

MRA is a world leader in advancing transformational science that has caused paradigm shifts in what it means to be diagnosed with and treated for melanoma. The innovative research we support isn’t just changing science — it’s giving patients more treatment options that translate to longer, fuller lives.

Read More

Overcoming Brain Mets & LMD: Sean Wachter’s Melanoma Journey

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 22 January 2024 In Melanoma Stories, Science, Treatment

Ten years ago, Sean Wachter never expected to have a loving spouse, children, or a life that feels worth living. That’s because, by his own admission, he’s done more living in the past 7 years than he did in the prior 31 as he overcame stage 4 melanoma with leptomeningeal disease...

Read More

New Research Alert: Melanoma and Microbiota: Current Understanding and Future Directions

8 January 2024 In Allies & Partnerships, Events, News, Science, Treatment

A perspective article summarizing the field’s current knowledge on how the gut microbiota affects melanoma response to immunotherapy, and how this knowledge can be used to improve patient outcomes was recently published in the journal Cancer Cell. 

Read More

Mindfulness During the Holidays: Tips for the Melanoma Community

By Stephanie Kauffman, MRA President & COO | 14 December 2023 In Allies & Partnerships, Events

While the holidays are a time to celebrate with family and friends, the season can quickly go from joyful to stressful for those living with a melanoma diagnosis. We have some suggestions on navigating the holidays

Read More

Clinical Trials to Watch: December 2023

By Joan Levy, PhD - MRA Chief Science Officer | 13 December 2023 In Allies & Partnerships, News, Science, Treatment

Treatment of advanced melanoma has dramatically improved over the past decade with 16 new therapies approved by the Food and Drug Administration (FDA). Even with these treatment advances, 50% of patients with advanced melanoma will either not respond to any of these treatments or their disease will progress creating a...

Read More

Shop for the Holidays and Give Back to MRA

By Laurel Farr, MRA Development Associate | 12 December 2023 In Allies & Partnerships, Events

The MRA community has given us so much throughout 2023 and we wanted to give back this holiday season with some tips, ideas, and discounts to help make your holiday gift-giving more meaningful and memorable. MRA’s incredible partners offer fantastic products that not only make thoughtful presents but also contribute to melanoma research. Here is our quick guide to meaningful and memorable gifts with special discounts for the MRA community.

Read More

Registration Now Open: MRA's 2024 Patient Forum

11 December 2023 In Allies & Partnerships, Events, Melanoma Stories, News, Policy, Prevention, Science, Treatment

Registration for MRA's Melanoma Exchange Patient Forum, held in-person in Washington DC and virtually on Wednesday, February 21, is now open. Register now to hear from leading experts in the melanoma field and have the opportunity to ask questions, discuss, and network with other people who are going through their own melanoma journey.

Read More

Perseverance through Advanced Melanoma: Clay Hummer

By Renee Orcione, MRA Digital Engagement & Communications Manager | 15 November 2023 In Melanoma Stories, Prevention, Science, Treatment

Clay Hummer is no stranger to perseverance, and his journey to today was not always easy. He gave up a career in law that he worked hard for to get completely sober and start a fresh chapter, moving to Texas in his 40s where he met the love of his life Christi. So, when he was diagnosed with melanoma shortly after his move, he knew quite a bit about overcoming a challenge.

Read More

Artificial Intelligence and Imaging in Melanoma Care: An Update

13 November 2023 In Allies & Partnerships, Events, Prevention, Science, Treatment

An early melanoma diagnosis is more likely to have a positive outcome than one diagnosed later. That’s a fact, but patients often delay having skin lesions checked for a variety of reasons, including long wait times to see a dermatologist—if they can even find one close by.

Read More

A Message from Our CEO on Veterans Day

By Marc Hurlbert, PhD, MRA Chief Executive Officer | 11 November 2023 In Allies & Partnerships, Events, Melanoma Stories, News, Policy, Prevention, Science, Treatment

On this Veterans Day, we want to express our sincere gratitude and appreciation for the brave individuals who have served and sacrificed for our country. We also want to use today to raise awareness about the unique challenges faced by veterans when it comes to increased risk of developing melanoma,...

Read More